Related Experiment Video
Updated: Sep 1, 2025

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
Published on: August 27, 2021
Optimal Wireless Reflux Monitoring Metrics to Predict Discontinuation of Proton Pump Inhibitor Therapy
Rena Yadlapati1, C Prakash Gyawali2, Melina Masihi3
1Division of Gastroenterology, University of California, San Diego School of Medicine, La Jolla, California, USA.
For gastroesophageal reflux disease (GERD) unresponsive to proton pump inhibitors (PPIs), 96-hour wireless pH monitoring is recommended. A total acid exposure time (AET) of 4.0% best predicts successful PPI discontinuation.
Area of Science:
- Gastroenterology
- Gastroesophageal Reflux Disease (GERD)
- Diagnostic Testing
Background:
- Ambulatory reflux monitoring off proton pump inhibitor (PPI) is the gold standard for diagnosing nonerosive GERD.
- Optimal diagnostic metrics and duration for this monitoring are not well-defined.
- Patients with suboptimal PPI response require refined diagnostic approaches.
Purpose of the Study:
- To evaluate diagnostic metrics and optimal duration of wireless reflux monitoring off PPI.
- To assess the performance of these metrics in predicting PPI discontinuation in patients with suboptimal PPI response.
Main Methods:
- A single-arm clinical trial enrolled adults with GERD symptoms and inadequate PPI response.
- Participants underwent 96-hour wireless pH monitoring off PPI.
- The primary outcome was successful PPI discontinuation within 3 weeks.
Main Results:
- 30% of 132 participants discontinued PPI.
- A total acid exposure time (AET) of 4.0% best predicted PPI discontinuation (OR 2.9).
- 96-hour monitoring outperformed 48-hour monitoring in predicting PPI discontinuation (AUC 0.63 vs 0.57).
Conclusions:
- A 4.0% AET threshold is a high-performing prognostic marker for PPI discontinuation.
- 96 hours of monitoring is superior to 48 hours for predicting PPI discontinuation.
- These findings can inform GERD diagnostic strategies for PPI-unresponsive patients.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...

